GH logo

Guardant Health Inc (GH)

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a...

NASDAQHealthcareDiagnostics & ResearchUSA

Company Profile

Stock Code
GH
ISIN Code
US40131M1099
Currency
US Dollar (USD)
IPO Date
2018-10-04

Contact Information

Company Address
3100 Hanover Street, Palo Alto, CA, United States, 94304
Contact Phone
855 698 8887
Company Website
https://guardanthealth.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
-18.07%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99